Author Correction: The current landscape of nucleic acid therapeutics

Jayesh A Kulkarni^#^{1

2

3}, Dominik Witzigmann^#^{2

3

4}, Sarah B Thomson¹, Sam Chen⁵, Blair R Leavitt¹, Pieter R Cullis^{2

4}, Roy van der Meel⁶

Affiliations

¹ Centre for Molecular Medicine and Therapeutics, Department of Medical Genetics, BC Children's Hospital Research Institute, University of British Columbia, Vancouver, British Columbia, Canada.
² NanoMedicines Innovation Network, Vancouver, British Columbia, Canada.
³ NanoVation Therapeutics, Vancouver, British Columbia, Canada.
⁴ Department of Biochemistry and Molecular Biology, University of British Columbia, Vancouver, British Columbia, Canada.
⁵ Integrated Nanotherapeutics, Vancouver, British Columbia, Canada.
⁶ Laboratory of Chemical Biology, Department of Biomedical Engineering and Institute for Complex Molecular Systems, Eindhoven University of Technology, Eindhoven, The Netherlands. r.v.d.meel@tue.nl.

^# Contributed equally.

Published Erratum

Jayesh A Kulkarni et al. Nat Nanotechnol. 2021 Jul.

. 2021 Jul;16(7):841.

doi: 10.1038/s41565-021-00937-w.

Jayesh A Kulkarni^#^{1

2

3}, Dominik Witzigmann^#^{2

3

4}, Sarah B Thomson¹, Sam Chen⁵, Blair R Leavitt¹, Pieter R Cullis^{2

4}, Roy van der Meel⁶

¹ Centre for Molecular Medicine and Therapeutics, Department of Medical Genetics, BC Children's Hospital Research Institute, University of British Columbia, Vancouver, British Columbia, Canada.
² NanoMedicines Innovation Network, Vancouver, British Columbia, Canada.
³ NanoVation Therapeutics, Vancouver, British Columbia, Canada.
⁴ Department of Biochemistry and Molecular Biology, University of British Columbia, Vancouver, British Columbia, Canada.
⁵ Integrated Nanotherapeutics, Vancouver, British Columbia, Canada.
⁶ Laboratory of Chemical Biology, Department of Biomedical Engineering and Institute for Complex Molecular Systems, Eindhoven University of Technology, Eindhoven, The Netherlands. r.v.d.meel@tue.nl.

^# Contributed equally.

No abstract available

Erratum for

The current landscape of nucleic acid therapeutics.
Kulkarni JA, Witzigmann D, Thomson SB, Chen S, Leavitt BR, Cullis PR, van der Meel R. Kulkarni JA, et al. Nat Nanotechnol. 2021 Jun;16(6):630-643. doi: 10.1038/s41565-021-00898-0. Epub 2021 May 31. Nat Nanotechnol. 2021. PMID: 34059811 Review.

Noncoding RNA therapeutics for substance use disorder.
Seyednejad SA, Sartor GC. Seyednejad SA, et al. Adv Drug Alcohol Res. 2022;2:10807. doi: 10.3389/adar.2022.10807. Epub 2022 Dec 20. Adv Drug Alcohol Res. 2022. PMID: 36601439 Free PMC article.
The Fomivirsen, Patisiran, and Givosiran Odyssey: How the Success Stories May Pave the Way for Future Clinical Translation of Nucleic Acid Drugs.
Mansouri M, Mansouri K, Taheri Z, Hossaini Alhashemi S, Dehshahri A. Mansouri M, et al. BioDrugs. 2025 May;39(3):359-371. doi: 10.1007/s40259-025-00711-7. Epub 2025 Apr 5. BioDrugs. 2025. PMID: 40186723 Review.
Non-viral vectors for RNA delivery.
Yan Y, Liu XY, Lu A, Wang XY, Jiang LX, Wang JC. Yan Y, et al. J Control Release. 2022 Feb;342:241-279. doi: 10.1016/j.jconrel.2022.01.008. Epub 2022 Jan 10. J Control Release. 2022. PMID: 35016918 Free PMC article. Review.
Role of long noncoding RNA in regulating HIV infection-a comprehensive review.
Amir N, Taube R. Amir N, et al. mBio. 2024 Feb 14;15(2):e0192523. doi: 10.1128/mbio.01925-23. Epub 2024 Jan 5. mBio. 2024. PMID: 38179937 Free PMC article. Review.
The application of nanoparticles in theranostic systems targeting breast cancer stem cells: current progress and future challenges.
Lin X, Wang Y, Fang K, Guo Z, Lin N, Li L. Lin X, et al. Stem Cell Res Ther. 2023 Dec 10;14(1):356. doi: 10.1186/s13287-023-03584-1. Stem Cell Res Ther. 2023. PMID: 38072976 Free PMC article. Review.